Open Peer Review Reports for: Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes
Pre-publication versions of this article are available by contacting info@biomedcentral.com.
| Original Submission | ||
|---|---|---|
| 7 Feb 2014 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 17 Feb 2014 | Reviewed | Reviewer Report - Zachary Bloomgarden |
| 25 Feb 2014 | Reviewed | Reviewer Report - Jeremy Walker |
| 8 Mar 2014 | Author responded | Author comments - Alice Kong |
| Resubmission - Version 3 | ||
| 8 Mar 2014 | Submitted | Manuscript version 3 |
| 11 Mar 2014 | Reviewed | Reviewer Report - Zachary Bloomgarden |
| 19 Mar 2014 | Author responded | Author comments - Alice Kong |
| Resubmission - Version 4 | ||
| 19 Mar 2014 | Submitted | Manuscript version 4 |
| 25 Mar 2014 | Author responded | Author comments - Alice Kong |
| Resubmission - Version 5 | ||
| 25 Mar 2014 | Submitted | Manuscript version 5 |
| Publishing | ||
| 25 Mar 2014 | Editorially accepted | |
| 13 May 2014 | Article published | 10.1186/1741-7015-12-76 |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.
